Naperville, IL -- (ReleaseWire) -- 10/29/2012 -- Fresenius Kabi to Acquire Fenwal - A Move to Expand its Transfusion Technology Business provides key insights on the deal. The report provides an analysis on the growth strategies of Fresenius Kabi to expand its transfusion technology business, Fenwal’s complementary product portfolio, expansion opportunities for Fresenius Kabi in the US market, and growth in the transfusion technology market.
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry.
- Qualitative analysis on Fresenius Kabi’s acquisition of Fenwal.
- Market penetration of Fresenius Kabi in the transfusion technology market.
- Company profiles of Fresenius Kabi AG and Fenwal, Inc.
Reasons to buy
- Understand the business strategy behind this deal by a medical device company to strengthen its current product portfolio and enter new product segments showing positive future growth trend.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the global regenerative medicine market
To view table of contents for this market report please visit: